Study of a Home Delivered Meal Program on Obese Elderly African American Subjects With Type 2 Diabetes Mellitus (DM)
- Conditions
- ObesityDiabetes
- Registration Number
- NCT00743756
- Lead Sponsor
- Emory University
- Brief Summary
The purpose of this study is to assess the impact of home-delivered Medical Nutrition Therapy on clinical outcomes for persons with diabetes. The primary outcomes of this studies include A1c (A1C), blood glucose, blood pressure, Body Mass Index, lipid levels and other measures of disease progression and management as well as costs of medical care provided throughout the intervention period.
- Detailed Description
Data collected as a result of this project will be evaluated in aggregate to demonstrate the potential impacts on health and medical costs available through this type of intervention, with long-term goals of reducing disability and deaths due to chronic disease.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 38
- African-American subjects
- Males or females 65 - 85 years of age
- Body mass index (BMI) equal to or greater than 30 kg/m2
- Fasting blood glucose less than 300 mg/dL and HbA1c less than 9.0%
- Ability to understand and be willing to adhere to the study protocol
- A known history of type 2 diabetes mellitus greater than 3 months, receiving either diet alone or oral antidiabetic agents (sulfonylureas, metformin, thiazolidinediones).
- Subjects with a history of diabetic ketoacidosis and hyperosmolar hyperglycemic state.
- Patients with clinically relevant hepatic disease or impaired renal function, as shown by a serum creatinine greater than 3.0 mg/dL.
- Mental condition rendering the subject unable to understand the scope of the study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Weight Loss in the elderly african american population 6 months to 1 year
- Secondary Outcome Measures
Name Time Method Endothelial Function (assessed by pulse-wave analysis); sympathetic activity; insulin sensitivity 6 months to 1 year
Trial Locations
- Locations (1)
Grady Health System
🇺🇸Atlanta, Georgia, United States
Grady Health System🇺🇸Atlanta, Georgia, United States